Cronos Group (CRON) Stock
NMQ · CRON
3.33
Fundamentals
Market cap
$1.23B
Price / Earnings ratio
17.6x
Price / Sales ratio
6.9x
Price / Book ratio
1.1x
Return on assets
0.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Cronos Group
Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes PEACE NATURALS™, a global health and wellness platform, two adult-use brands, COVE™ and Spinach™, and three hemp-derived CBD brands, Lord Jones™, Happy Dance™ and PEACE+™.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees610
CEOMr. Michael Ryan Gorenstein J.D.
IPO DateJul 12, 2016
HeadquartersStayner, ON
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael Ryan Gorenstein J.D. | President, CEO & Chairman | 1987 |
| Ms. Anna Shlimak | Chief Financial Officer | 1986 |
| Ms. Shannon Buggy | Senior VP & Global Head of People | 1970 |
| Mr. Jeffrey David Jacobson | Chief Growth Officer | 1986 |
| Mr. Adam Wagner | General Manager of Cronos Israel | 1983 |
| Mr. Jared Matthew Kenost | VP, Principal Accounting Officer & Controller | — |
| Mr. Harrison Aaron | Senior Director of Investor Relations & Corporate Development | — |
| Mr. Terry Gregory-Joseph Doucet | General Counsel & Corporate Secretary | 1990 |
| Mr. Arye Weigensberg | Senior VP and Head of Research & Development | 1983 |
Fundamentals
Valuation
Market cap$1.23B
Price-to-sales ratio6.89
Price-to-book value1.15
Price-earnings ratio17.60
Return on Equity0.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$0.19
Income Statement
Average volume1,143,604
EBITDA$-37.16M
1 year high (52w)$3.61
1 year low (52w)$2.28
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



